173 related articles for article (PubMed ID: 2416199)
1. Protective immunity evoked by synthetic peptides of streptococcal M proteins.
Beachey EH
Adv Exp Med Biol; 1985; 185():193-200. PubMed ID: 2416199
[No Abstract] [Full Text] [Related]
2. Opsonic antibodies evoked by hybrid peptide copies of types 5 and 24 streptococcal M proteins synthesized in tandem.
Beachey EH; Gras-Masse H; Tarter A; Jolivet M; Audibert F; Chedid L; Seyer JM
J Exp Med; 1986 Jun; 163(6):1451-8. PubMed ID: 3519829
[TBL] [Abstract][Full Text] [Related]
3. Human secretory immune response to streptococcal M protein. Identification of a secretory IgA epitope in the exposed conserved region.
Yoshinaga M; Miyata K; Fischetti VA
Adv Exp Med Biol; 1997; 418():913-5. PubMed ID: 9331797
[No Abstract] [Full Text] [Related]
4. Immunogenicity of a polypeptide fragment of the streptococcal group A M protein conjugated with an acrylic acid N-vinylpyrrolidone copolymer.
Lyampert IM; Semenova EN; Sanina VYu ; Puchkova NG; Nekrasov AV
Biomed Sci; 1991; 2(4):410-4. PubMed ID: 1797145
[TBL] [Abstract][Full Text] [Related]
5. Repeating covalent structure and protective immunogenicity of native and synthetic polypeptide fragments of type 24 streptococcal M protein. Mapping of protective and nonprotective epitopes with monoclonal antibodies.
Beachey EH; Seyer JM; Dale JB; Hasty DL
J Biol Chem; 1983 Nov; 258(21):13250-7. PubMed ID: 6415061
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peptide fragments of streptococcal M proteins.
Seyer JM; Dale JB; Beachey EH
Dev Biol Stand; 1986; 63():101-8. PubMed ID: 2427375
[TBL] [Abstract][Full Text] [Related]
7. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments.
Dale JB
Vaccine; 1999 Jan; 17(2):193-200. PubMed ID: 9987154
[TBL] [Abstract][Full Text] [Related]
8. Estimation of type-specific anti-streptococcal M-protein antibodies with biotinylated peptides in human sera.
Kühnemund O; Schumacher F; Casaretto M; Holm SE; Lütticken R
APMIS; 1998 Feb; 106(2):288-92. PubMed ID: 9531961
[TBL] [Abstract][Full Text] [Related]
9. Recombinant tetravalent group A streptococcal M protein vaccine.
Dale JB; Chiang EY; Lederer JW
J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunisation of mice with a streptococcal peptide-based vaccine.
Relf W; Hayman W; Russell-Jones G; Good M
Adv Exp Med Biol; 1997; 418():859-61. PubMed ID: 9331788
[No Abstract] [Full Text] [Related]
11. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
Bessen D; Fischetti VA
J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
[TBL] [Abstract][Full Text] [Related]
12. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
Kraus W; Haanes-Fritz E; Cleary PP; Seyer JM; Dale JB; Beachey EH
J Immunol; 1987 Nov; 139(9):3084-90. PubMed ID: 2444650
[TBL] [Abstract][Full Text] [Related]
13. Mapping T-cell epitopes in group A streptococcal type 5 M protein.
Robinson JH; Atherton MC; Goodacre JA; Pinkney M; Weightman H; Kehoe MA
Infect Immun; 1991 Dec; 59(12):4324-31. PubMed ID: 1718873
[TBL] [Abstract][Full Text] [Related]
14. Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein.
Beachey EH; Seyer JM; Dale JB; Simpson WA; Kang AH
Nature; 1981 Jul; 292(5822):457-9. PubMed ID: 6166868
[No Abstract] [Full Text] [Related]
15. Mapping a conserved conformational epitope from the M protein of group A streptococci.
Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
[TBL] [Abstract][Full Text] [Related]
16. Group A streptococcus expresses a trio of surface proteins containing protective epitopes.
Niedermeyer SE; Penfound TA; Hohn C; Li Y; Homayouni R; Zhao J; Dale JB
Clin Vaccine Immunol; 2014 Oct; 21(10):1421-5. PubMed ID: 25080552
[TBL] [Abstract][Full Text] [Related]
17. Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein-derived peptides.
Aranha MP; Penfound TA; Spencer JA; Agarwal R; Baudry J; Dale JB; Smith JC
J Biol Chem; 2020 Mar; 295(12):3826-3836. PubMed ID: 32029479
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
Dale JB; Smeesters PR; Courtney HS; Penfound TA; Hohn CM; Smith JC; Baudry JY
Vaccine; 2017 Jan; 35(1):19-26. PubMed ID: 27890396
[TBL] [Abstract][Full Text] [Related]
19. Unique and common protective epitopes among different serotypes of group A streptococcal M proteins defined with hybridoma antibodies.
Dale JB; Beachey EH
Infect Immun; 1984 Oct; 46(1):267-9. PubMed ID: 6207110
[TBL] [Abstract][Full Text] [Related]
20. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci.
Jones KF; Fischetti VA
J Exp Med; 1988 Mar; 167(3):1114-23. PubMed ID: 2450950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
